FDA NDC Directory · JSON-LD · Markdown

Liothyronine Sodium

NDC 0093-2178 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211510
Dosage form / routeTABLET · ORAL
Active ingredientsLIOTHYRONINE SODIUM (25 ug/1)
Marketing started20210226
Package count1

External sources

Source: openFDA. Public-domain (CC0).